Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title: Editorial [Hot topic: Newly Recognized Actions of Vitamin D3 (Guest Editor: Ilka Nemere)]
Volume: 9 Issue: 3
Author(s): Ilka Nemere
Affiliation:
Export Options
About this article
Cite this article as:
Nemere Ilka, Editorial [Hot topic: Newly Recognized Actions of Vitamin D3 (Guest Editor: Ilka Nemere)], Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2009; 9 (3) . https://dx.doi.org/10.2174/187152209789760468
DOI https://dx.doi.org/10.2174/187152209789760468 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
11
Related Articles
-
Heat Shock Proteins Regulating Toll-like Receptors and the Immune System could be a Novel Therapeutic Target for Melanoma
Current Molecular Medicine Curcumin: A Promising Agent Targeting Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry Cytotoxicity of Novel Sulfanilamides Towards Sensitive and Multidrugresistant Leukemia Cells
Current Medicinal Chemistry MiRNAs in Human Cancers: The Diagnostic and Therapeutic Implications
Current Pharmaceutical Design The Role of Fibroblast Growth Factors in Tumor Growth
Current Cancer Drug Targets Natural Compounds as Antagonists of Canonical Wnt/β-Catenin Signaling
Current Chemical Biology CETUXIMAB: From Bench to Bedside
Current Cancer Drug Targets Structural and Functional Organization of miRNAs
Current Pharmacogenomics Etiopathogenesis, Classical Immunotherapy and Innovative Nanotherapeutics for Inflammatory Neurological Disorders
Current Nanoscience Novel Agents Targeting Bioactive Sphingolipids for the Treatment of Cancer
Current Medicinal Chemistry Aberrant Splicing, Hyaluronan Synthases and Intracellular Hyaluronan as Drivers of Oncogenesis and Potential Drug Targets
Current Cancer Drug Targets Ozone Depletion Explains Global Warming
Current Physical Chemistry Recent Advances in Receptor-Targeted Fluorescent Probes for In Vivo Cancer Imaging
Current Medicinal Chemistry Inhibitors of ER Aminopeptidase 1 and 2: From Design to Clinical Application
Current Medicinal Chemistry Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery The Role of Survivin for Radiation Oncology: Moving Beyond Apoptosis Inhibition
Current Medicinal Chemistry Cosmeceutical Aptitudes of Azelaic Acid
Current Drug Research Reviews Chemokine Like Receptor-1 (CMKLR-1) Receptor: A Potential Therapeutic Target in Management of Chemerin Induced Type 2 Diabetes Mellitus and Cancer
Current Pharmaceutical Design Novel Virally Targeted Therapies of EBV-Associated Tumors
Current Cancer Drug Targets Pieces of the Complex Puzzle of Cancer Cell Energy Metabolism: An Overview of Energy Metabolism and Alternatives for Targeted Cancer Therapy
Current Medicinal Chemistry